ASTRA and its associated studies, CIPHER and AURAH, present independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research funding scheme (RP-PG-0608-10142).

The studies were some of the components of CAPRA, a programme for the Comprehensive Assessment of the Prevention Role of Antiretroviral therapy.

The studies also received support through the Comprehensive Clinical Research Network.

This website is provided courtesy of University College London.

UCL Logo

CAPRA Final Report

13 December 2017

The CAPRA research programme which underpinned the ASTRA, AURAH and CIPHER studies (among others) produced its final report in November 2017.

The Comprehensive Assessment of the Prevention Role of Antiretroviral therapy programme aimed to assess whether a policy of offering antiretroviral therapy (ART) treatment to all people diagnosed with HIV in the UK would be acceptable, effective and cost-effective. One of its main conclusions was that ART initiation at diagnosis is likely to be cost-effective in MSM (men who have sex with men).

Further details are available from the NIHR Journals Library.